Valeant Pharmaceuticals International Inc


  • NEW YORK, Sept 16- Some of the top 20 investors at Salix Pharmaceuticals Ltd are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals SpA, and are pressing Salix to consider selling itself instead, people familiar with the matter said on Tuesday.

  • Allergan agrees to move forward with meeting Tuesday, 16 Sep 2014 | 6:35 AM ET

    NEW YORK— Allergan and Pershing Square have agreed on at least one step toward settling a fight over the makeup of the Botox-maker's board. Allergan will hold its special shareholders meeting as planned on Dec. 18, while Pershing Square and its partner, Valeant Pharmaceuticals, continue their push for control of the drugmaker.

  • Sept 16- Allergan Inc and its suitors Pershing Square Capital Management and Valeant Pharmaceuticals Inc settled their pending litigation before the Delaware Court of Chancery and agreed to hold a special shareholder meeting on the originally scheduled date, Dec. 18.

  • Ackman to Allergan board: 'Wake up' on Valeant talks Wednesday, 10 Sep 2014 | 6:21 AM ET
    William 'Bill' Ackman, founder and chief executive officer of Pershing Square Capital Management LP, speaks during an event in New York, U.S.

    William Ackman criticized Allergan's board of directors, urging them to "wake up" and at least listen to potential purchaser Valeant Pharmaceuticals.

  • BOSTON, Sept 9- After months of staying largely silent on a deal he is trying to broker, billionaire William Ackman on Tuesday criticized Allergan Inc' s board of directors, urging them to "wake up" and at least listen to what potential purchaser Valeant Pharmaceuticals has to offer the Botox maker.

  • TORONTO, Sept 5- Canada's main stock index finished Friday's session little changed, as modest, but broad, declines led by financial stocks, offset resource gains and investors kept to the sidelines. Toronto-Dominion Bank was off 0.52 percent at C $57.48, while Royal Bank of Canada slipped 0.4 percent to C $80.76.

  • WILMINGTON, Del., Aug 27- Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $49 billion hostile takeover fight.

  • Aug 27- A Delaware judge granted a request by Valeant Pharmaceuticals International Inc and Pershing Square Capital Management for expedited proceedings in a special meeting dispute with Allergan Inc.. Andre Bouchard of Delaware's Court of Chancery scheduled a three-day trial to start Oct. 6. Allergan had proposed a Nov. 24 trial.

  • Early movers: TIF, AAPL, T, AGN, PFE, TIVO & more Wednesday, 27 Aug 2014 | 8:13 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE) on Friday.

    Some of the names on the move ahead of the open.

  • Early movers: BKW, ANN, BBRY, ITMN, GS, SNE & more Monday, 25 Aug 2014 | 7:33 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Midday movers: Angie's List, Deere, McDonald's & more Friday, 22 Aug 2014 | 12:58 PM ET
    Trader on the floor of the New York Stock Exchange.

    Some of Friday's midday movers:

  • NEW YORK/ BOSTON, Aug 20- A few months ago, an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan Inc looked like a blueprint for success.

  • Aug 19- Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street Journal said. Allergan and Salix declined to comment on the matter.

  • Midday movers: Apple, Fabrinet, Lear & more Monday, 18 Aug 2014 | 12:57 PM ET
    A woman walks down a staircase at the Wall Street subway station, New York City.

    Some of Monday's midday movers:

  • Aug 14- Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock.

  • Aug 14- U.S. securities regulators are looking at the hostile takeover bid made by billionaire investor William Ackman and Valeant Pharmaceuticals for Botox maker Allergan Inc, a person familiar with the matter said on Thursday.

  • Aug 14- A hostile takeover bid by billionaire investor William Ackman and Valeant Pharmaceuticals International Inc to acquire Allergan Inc is being investigated by federal regulators for possible violations of securities laws, the Wall Street Journal reported, citing people familiar with the matter.

  • SEC looking into Ackman offer for Allergan: DJ Thursday, 14 Aug 2014 | 1:29 PM ET
    Bill Ackman

    Securities regulators are looking into the joint bid by Valeant Pharmaceuticals and activist investor Bill Ackman for Allergan, Dow Jones reported.

  • *Equities have come under pressure because of the problems between Russia and Ukraine, with the S&P 500 at one point down about 4 percent from a record closing high in late July. *The gain implied by futures came despite ongoing concerns about the region, with Ukraine reporting that Russia had massed 45,000 troops on its border.

  • Rupert Murdoch triggered M&A shockwave Monday, 11 Aug 2014 | 10:52 AM ET
    Rupert Murdoch

    When Rupert Murdoch and Masayoshi Son walked away from their deals last week, the moguls created a shock wave on Wall Street.